First safety check for new antibiotic in sick kids
NCT ID NCT04223752
Summary
This early-stage study tested the safety and how the body processes the antibiotic combination ceftolozane/tazobactam in children with hospital-acquired pneumonia. It involved 41 hospitalized children who were already receiving standard antibiotic care. The main goal was to see if the drug was safe and to measure its levels in the children's blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NOSOCOMIAL PNEUMONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AdventHealth Orlando ( Site 1318)
Orlando, Florida, 32803, United States
-
Children's Wisconsin ( Site 1321)
Milwaukee, Wisconsin, 53226, United States
-
Ciensalud Ips S A S ( Site 1501)
Barranquilla, Atlántico, 08001, Colombia
-
Clinica de la Costa S.A.S. ( Site 1500)
Barranquilla, Atlántico, 080020, Colombia
-
Hippokration General Hospital of Thessaloniki ( Site 0400)
Thessaloniki, Central Macedonia, 546 42, Greece
-
Hospital General de Medellin ( Site 1503)
Medellín, Antioquia, 0500515, Colombia
-
Hospital Infantil de Mexico Federico Gomez-Infectious Diseases ( Site 1600)
Mexico City, Mexico City, 06720, Mexico
-
Hospital Roberto del Río ( Site 1400)
Santiago, Region M. de Santiago, 8380418, Chile
-
Hospital Universitario Sant Joan de Deu ( Site 1100)
Esplugues de Llobregat, Barcelona, 08950, Spain
-
Institution of Pediatr Obstetr and Gynec NAMS of Ukraine ( Site 1203)
Kyiv, Kyivska Oblast, 04050, Ukraine
-
Instituto Nacional de Pediatria-Unidad de Apoyo a la Investigación Clínica ( Site 1602)
Mexico City, Mexico City, 04530, Mexico
-
Ivano-Frankivsk Regional Children Clinical Hospital ( Site 1204)
Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76018, Ukraine
-
Kharkiv City Children Hospital 16 ( Site 1200)
Kharkiv, Kharkivs’ka Oblast’, 61075, Ukraine
-
Mayo Clinic in Rochester, Minnesota ( Site 1322)
Rochester, Minnesota, 55902, United States
-
Montefiore Medical Center [Bronx, NY] ( Site 1313)
New York, New York, 10467, United States
-
Morozovskaya Children City Clinical Hospital ( Site 0901)
Moscow, Moscow, 119049, Russia
-
Oncomédica S.A.S ( Site 1506)
Montería, Departamento de Córdoba, 230002, Colombia
-
SA Tallinna Lastehaigla/Tallinn Children's Hospital ( Site 0201)
Tallinn, Harju, 13419, Estonia
-
SA Tartu Ulikooli Kliinikum Lastekliinik ( Site 0200)
Tartu, Tartu, 50406, Estonia
-
SI Dnipropetrovsk Regional Children Clinical Hospital DOR ( Site 1205)
Dnipro, Dnipropetrovsk Oblast, 49100, Ukraine
-
Sanford Children's Hospital ( Site 1301)
Sioux Falls, South Dakota, 57105, United States
-
Smolensk Regional Clinical Hospital ( Site 0903)
Smolensk, Smolensk Oblast, 214018, Russia
-
St. Olga Children City Hospital ( Site 0906)
Saint Petersburg, Sankt-Peterburg, 194156, Russia
-
West Virginia University ( Site 1310)
Morgantown, West Virginia, 26506, United States
Conditions
Explore the condition pages connected to this study.